WO2001039752A3 - Transdermales therapeutisches system enthaltend leicht flüchtige wirkstoffe - Google Patents

Transdermales therapeutisches system enthaltend leicht flüchtige wirkstoffe Download PDF

Info

Publication number
WO2001039752A3
WO2001039752A3 PCT/EP2000/011169 EP0011169W WO0139752A3 WO 2001039752 A3 WO2001039752 A3 WO 2001039752A3 EP 0011169 W EP0011169 W EP 0011169W WO 0139752 A3 WO0139752 A3 WO 0139752A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredients
highly volatile
therapeutic system
containing highly
system containing
Prior art date
Application number
PCT/EP2000/011169
Other languages
English (en)
French (fr)
Other versions
WO2001039752A2 (de
Inventor
Ralf Kibele
Karin Klokkers
Hans-Juergen Schlueter
Original Assignee
Hexal Ag
Ralf Kibele
Karin Klokkers
Schlueter Hans Juergen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag, Ralf Kibele, Karin Klokkers, Schlueter Hans Juergen filed Critical Hexal Ag
Priority to DE50014096T priority Critical patent/DE50014096D1/de
Priority to EP00976023A priority patent/EP1231906B1/de
Priority to AU13937/01A priority patent/AU1393701A/en
Publication of WO2001039752A2 publication Critical patent/WO2001039752A2/de
Publication of WO2001039752A3 publication Critical patent/WO2001039752A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein pharmazeutisches, therapeutisches System in Form eines Pflasters, welches leicht flüchtige Wirkstoffe als aktive Bestandteile in einem Membransystem enthält, wobei die Deckschicht einen reversiblen Verbund ist, der durch eine Siegelung von annähernd wirkstoffundurchlässigem Polyester gegen eine wirkstoffdurchlässige Polymermembran hergestellt wird. Die annähernd wirkstoffundurchlässige Polyesterfolie kann vor Gebrauch abgezogen werden.
PCT/EP2000/011169 1999-11-27 2000-11-11 Transdermales therapeutisches system enthaltend leicht flüchtige wirkstoffe WO2001039752A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE50014096T DE50014096D1 (de) 1999-11-27 2000-11-11 Transdermales therapeutisches system enthaltend leich flüchtige wirkstoffe
EP00976023A EP1231906B1 (de) 1999-11-27 2000-11-11 Transdermales therapeutisches system enthaltend leich flüchtige wirkstoffe
AU13937/01A AU1393701A (en) 1999-11-27 2000-11-11 Transdermal therapeutic system containing highly volatile active ingredients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19957234.8 1999-11-27
DE19957234A DE19957234A1 (de) 1999-11-27 1999-11-27 Pharmazeutisches Pflaster enthaltend ätherische Öle

Publications (2)

Publication Number Publication Date
WO2001039752A2 WO2001039752A2 (de) 2001-06-07
WO2001039752A3 true WO2001039752A3 (de) 2001-12-06

Family

ID=7930621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011169 WO2001039752A2 (de) 1999-11-27 2000-11-11 Transdermales therapeutisches system enthaltend leicht flüchtige wirkstoffe

Country Status (5)

Country Link
EP (1) EP1231906B1 (de)
AT (1) ATE354357T1 (de)
AU (1) AU1393701A (de)
DE (2) DE19957234A1 (de)
WO (1) WO2001039752A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10063378A1 (de) * 2000-12-19 2002-06-20 Labtec Gmbh Aufkleber mit Verflüssigungsmittel für natürliche Atemwegssekrete
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
DE10220114A1 (de) * 2002-05-06 2003-11-20 Beiersdorf Ag Ätherische Öle enthaltendes Matrixpflaster auf Polyurethanbasis
DE10239101B4 (de) * 2002-08-27 2005-06-16 Scs Skin Care Systems Gmbh Pflaster zur Verabreichung von Deodorantien
DE10246377B4 (de) * 2002-10-04 2007-01-11 Beiersdorf Ag Verfahren zur Herstellung von Pflastersystemen mit dotierten Trägermaterialien als Reservoir
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
DE10341933A1 (de) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
CN101553205A (zh) * 2006-10-17 2009-10-07 拉伯泰克技术研发有限公司 含苦味剂和天然呼吸道分泌物液化剂的粘附标签
DE102007023021A1 (de) * 2007-03-26 2008-10-02 Angelika-Regine Dr. med. Dietz Therapeutisches Pflaster für Trigger- und Akupunkturpunkte sowie zur Meridiantherapie
DE102008059054A1 (de) 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
EP2968200A1 (de) * 2013-03-14 2016-01-20 Avery Dennison Corporation Stabilisierung von ätherischen ölen in einem hydrokolloidkleber
DE102013008726A1 (de) 2013-05-23 2014-11-27 Amw Gmbh Plaster mit Abziehhilfe
EP2878313A1 (de) * 2013-11-29 2015-06-03 LTS LOHMANN Therapie-Systeme AG Heftpflaster enthaltend ätherische Öle und Verfahren zu seiner Herstellung
CN116265023A (zh) * 2021-12-16 2023-06-20 北京远大九和药业有限公司 一种预防和/或治疗耳部感染的药物组合物及其制备方法和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000115A1 (en) * 1991-06-28 1993-01-07 Fischel Ghodsian Fariba Device for controlled release of vaporous medications and insect-repellents
DE4433191A1 (de) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3216609A1 (de) * 1982-05-04 1983-11-10 Dietic Dr. Widmann Pharma + Diät GmbH, 6930 Eberbach Pflaster-inhalat
DE3629565A1 (de) * 1986-08-30 1988-03-03 Arno W Latzke Mittel zur applikation von transdermal resorbierbaren wirkstoffen
HU203285B (en) * 1988-02-01 1991-07-29 Egyt Gyogyszervegyeszeti Gyar Method for producing transdermal preparation containing vegetable extract
DE3911617A1 (de) * 1988-10-12 1990-04-19 Klaus Brueckner Darreichungsform fuer arzneistoffe
DE29511982U1 (de) * 1995-07-26 1996-02-22 Hexal Pharma GmbH, 83607 Holzkirchen Pflaster
GB9720479D0 (en) * 1996-10-23 1997-11-26 Le Gall Madeleine Dressing
DE29620182U1 (de) * 1996-11-20 1997-04-10 Bb Med Product Gmbh Humantherapeutisches Erzeugnis zur Behandlung und/oder Vorbeugung von Krankheiten durch Dämpfe von ätherischen Ölen
DE19712359A1 (de) * 1997-03-25 1998-10-01 Labtec Gmbh System zur Arzneistoffinhalation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000115A1 (en) * 1991-06-28 1993-01-07 Fischel Ghodsian Fariba Device for controlled release of vaporous medications and insect-repellents
DE4433191A1 (de) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers

Also Published As

Publication number Publication date
WO2001039752A2 (de) 2001-06-07
EP1231906A2 (de) 2002-08-21
AU1393701A (en) 2001-06-12
DE19957234A1 (de) 2001-06-28
DE50014096D1 (de) 2007-04-05
EP1231906B1 (de) 2007-02-21
ATE354357T1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
WO2001039752A3 (de) Transdermales therapeutisches system enthaltend leicht flüchtige wirkstoffe
AU3912089A (en) Multilayer plaster
AU679032B2 (en) Transdermal therapeutic system with galanthamine as active ingredient
WO2002003969A3 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
WO2001003917A3 (de) Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
CA2509670A1 (en) Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
WO2005079750A3 (en) Films for use as dosage forms
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
WO2002022109A3 (en) Patch comprising diclofenac
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
JP2002514523A (ja) 受容体に適用する積層品
HK1053441A1 (en) Packaging for a plaster containing active ingredients
AU695970B2 (en) Estradiol-TTS having water-binding additives
JPS577412A (en) Plaster
JPH01100115A (ja) 貼付剤
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000976023

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000976023

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000976023

Country of ref document: EP